Navigation Links
The Leukemia & Lymphoma Society Available to Comment on FDA Approval of Seattle Genetics' Adcetris, First New Treatment for Hodgkin Lymphoma Since 1977
Date:8/19/2011

WHITE PLAINS, N.Y., Aug. 19, 2011 /PRNewswire/ -- Today the Food and Drug Administration (FDA) approved Seattle Genetics' Adcetris to treat two types of rare blood cancers – Hodgkin lymphoma and anaplastic large cell lymphoma (ALCL).

(Logo: http://photos.prnewswire.com/prnh/20110215/NY48642LOGO)

The drug is approved for Hodgkin lymphoma patients after failure of a stem cell transplant or two chemotherapy treatments and for ALCL patients after failure of at least one multi-agent chemotherapy treatment.

"This is a great advance for patients battling both of these diseases," said Hildy Dillon, Senior Vice President of Patient Services for The Leukemia & Lymphoma Society. "These are both considered very curable diseases but there is a population of patients from both diseases for whom treatment has not been effective."

Hodgkin lymphoma has an 86 percent survival and ALCL has an 80 percent cure rate.

"But for those people who don't respond well these can be very difficult cancers to cure. This advance gives new hope to that group of patients," Dillon said.

Dillon added that Seattle Genetics should be commended for investing in a therapy for a very small subgroup of patients who don't respond to standard therapy and for whom there were very limited options until now.

There are nearly 9,000 new cases of Hodgkin lymphoma diagnosed each year and 3,000 new cases of ALCL, and both diseases primarily impact children in their late teens and young adults.  Adcetris is a targeted therapy linking a tumor-targeting antibody to a chemotherapy drug with the goal of limiting side effects.

About The Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. www.LLS.org.

For LLS Contact:
Andrea Greif
Work: 914-821-8958
Cell: 914-772-3027
andrea.greif@lls.org


'/>"/>
SOURCE The Leukemia & Lymphoma Society
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Perdue Kidd & Vickery Files Lawsuit Against Abbott Laboratories for Inadequate Leukemia and Cancer Warning
2. Recent Study Shows Leukothera™ Combined with Other Agents Has Enhanced Anti-Leukemia Effects
3. Financial Assistance Now Available for People with Acute Lymphoblastic Leukemia
4. Omeros Unlocks Orphan GPCRs Linked to Leukemia and Sleep Disorders
5. Wake Forest Baptist Medical Center and Cornerstone Pharmaceuticals Present Interim Data From Phase I Trial of CPI-613 in Acute Myeloid Leukemia
6. Medco Partners With MolecularMD on Personalized Medicine Program for Chronic Myeloid Leukemia
7. Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Peptides
8. Reportlinker Adds Triple Analysis: Breast Cancer, Leukemia and Cancer Vaccines
9. Reportlinker Adds Triple Analysis: Leukemia, Lymphoma and Pancreatic Cancer
10. Reportlinker Adds Triple Analysis: Leukemia, Prostate Cancer and Apoptosis
11. Reportlinker Adds Triple Analysis: Colorectal Cancer, Leukemia and Apoptosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... BERLIN , April 29, 2016 ... world-leading glyco-biology expertise, today announces the appointment of Dr. ... Dr. Zurlo is an oncologist with many years ... pharmaceutical and biotechnology industries. His last role was at ... Member of the Executive Board. Previously Dr. Zurlo held ...
(Date:4/28/2016)... , April 28, 2016  While Abbott,s ... complement the company,s valve repair and stent business, ... also places Abbott more firmly into patient monitoring.  ... the fastest growing device areas, with double-digit growth ... recent report,  Advanced Remote Patient Monitoring ...
(Date:4/28/2016)... April 28, 2016 ... George Phillips und Stephen Schmidt ... ArisGlobal®, ein führender Anbieter cloudbasierter ... heute bekannt, dass neue Führungskräfte zum Team ... sind, die vielfältige Erfahrungen mitbringen.  Dies wird ...
Breaking Medicine Technology:
(Date:5/2/2016)... ... May 02, 2016 , ... Pets bring laughter, joy and ... appreciation, pet owners celebrate National Pet Week, which falls on the first full week ... owners to cherish the human-animal bond and recognize responsible pet ownership. Pet owners can ...
(Date:5/2/2016)... ... May 02, 2016 , ... The Civilian Corps of the U.S. Army Medical ... that care for its uniformed service members, the retired service members, their families and ... 6th through May 12th National Nurses Week. It acknowledges the hard work and dedication ...
(Date:5/2/2016)... ... May 02, 2016 , ... ... help consumers better understand life insurance throughout various life stages. , The site ... life insurance needs calculator and content specific to the times when life insurance ...
(Date:5/2/2016)... ... May 02, 2016 , ... In honor of National Physical ... incentive to people who share their fitness journey on social media. , The ... products, will award a $100 product voucher each week during May to one winner. ...
(Date:5/2/2016)... ... , ... WestHarbor Growth Partners, a growth, expansion and turnaround ... Healthy Vending’s newly revamped brand campaign. Grow Healthy Vending is headquartered in ... North America with locations across the United States as well as internationally. ...
Breaking Medicine News(10 mins):